Home 
Bratislava Medical Journal 2023 Bratislava Medical Journal Vol.124, No.7, p.527–533, 2023
Bratislava Medical Journal 2023 Bratislava Medical Journal Vol.124, No.7, p.527–533, 2023
Journal info
|
||||
Select Journal
Journals
Bratislava Medical Journal 2024 Ahead of print 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 Endocrine Regulations General Physiology and Biophysics Neoplasma Acta Virologica Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudbaWebshop Cart
Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.
Bratislava Medical Journal Vol.124, No.7, p.527–533, 2023 |
||
| Title: MiR-126 and miR-146a as markers of type 2 diabetes mellitus: a pilot study | ||
| Author: Jakub BENKO, Miroslava SARLINOVA, Veronika MIKUSOVA, Tomas BOLEK, Martin Jozef PEC, Erika HALASOVA, Peter GALAJDA, Matej SAMOS, Marian MOKAN | ||
| Abstract: INTRODUCTION: Despite known risk factors for developing type 2 diabetes mellitus (T2D), the research community still tries to discover new markers that would widen our diagnostic and therapeutic approach to diabetes. Therefore, research on microRNA (miR) in diabetes thrives. This study aimed to assess the utility of miR-126, miR-146a, and miR-375 as novel diagnostic markers for T2D. METHODS: We examined relative quantities of miR-126, miR-146a, and miR-375 in the serum of patients with established type 2 diabetes mellitus (n = 68) and compared these with a control group (n = 29). We also undertook a ROC analysis of significantly changed miR to examine their use as a diagnostic test. RESULTS: MiR-126 (p < 0.0001) and miR-146a (p = 0.0005) showed a statistically significant reduction in patients with type 2 diabetes mellitus. MiR-126 also proved to be an exceptional diagnostic test in our study cohort, with high sensitivity (91 %) and specificity (97 %). We did not find any difference in our study groups’ relative quantities of miR-375. CONCLUSION: The study proved a statistically significant reduction of miR-126 and miR-146a in patients with T2D (Tab. 4, Fig. 6, Ref. 51). Text in PDF www.elis.sk |
||
| Keywords: microRNA, epigenetics, genomics, type 2 diabetes mellitus, miR-126, miR-146a and miR-375 | ||
| Published online: 12-May-2023 | ||
| Year: 2023, Volume: 124, Issue: 7 | Page From: 527, Page To: 533 | |
| doi:10.4149/BLL_2023_081 |
||
|
|
 download file |
|